| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.439 | 45.269 | 22.323 | 63.459 | 147.233 | 705.098 | 909.637 | 1.291.005 | 2.027.404 | 2.929.386 |
| Total Income - EUR | 41.504 | 57.739 | 22.359 | 63.868 | 147.337 | 705.894 | 909.735 | 1.291.810 | 2.081.290 | 2.965.564 |
| Total Expenses - EUR | 30.497 | 30.111 | 22.972 | 17.479 | 42.830 | 623.296 | 872.601 | 1.121.666 | 1.687.018 | 2.398.412 |
| Gross Profit/Loss - EUR | 11.007 | 27.628 | -613 | 46.390 | 104.507 | 82.598 | 37.134 | 170.143 | 394.272 | 567.152 |
| Net Profit/Loss - EUR | 9.764 | 25.899 | -4.581 | 44.898 | 103.033 | 75.906 | 28.946 | 160.579 | 348.877 | 516.086 |
| Employees | 1 | 1 | 1 | 1 | 5 | 9 | 13 | 13 | 15 | 19 |
Check the financial reports for the company - Medgin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 50.065 | 37.902 | 29.812 | 23.166 | 255.501 | 369.216 | 416.755 | 331.401 | 1.193.807 | 1.817.651 |
| Current Assets | 118.978 | 50.294 | 46.379 | 91.387 | 100.442 | 127.649 | 115.091 | 154.265 | 578.837 | 554.895 |
| Inventories | 0 | 0 | 0 | 0 | 34.092 | 31.889 | 23.857 | 2.249 | 768 | 0 |
| Receivables | 107.703 | 46.559 | 43.096 | 55.791 | 43.385 | 16.496 | 33.057 | 13.823 | 236.151 | 146.197 |
| Cash | 11.276 | 3.735 | 3.284 | 35.595 | 22.964 | 79.264 | 58.177 | 138.193 | 341.917 | 408.698 |
| Shareholders Funds | 106.294 | 35.616 | 30.433 | 74.772 | 120.902 | 167.749 | 192.975 | 206.009 | 518.357 | 870.021 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 62.749 | 52.580 | 45.759 | 39.781 | 235.040 | 329.116 | 338.872 | 279.657 | 1.056.454 | 1.335.904 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.833 | 167.109 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medgin Srl